24 мая 2023 г. · Anticoagulation with direct oral anticoagulants (DOACs) reduces the risk of ischemic stroke and systemic embolism among persons with atrial fibrillation. |
17 июн. 2024 г. · The ELAN trial showed possible benefit of early anticoagulation compared with delayed anticoagulation after acute ischemic stroke and AF. |
16 мая 2024 г. · We found no evidence of major treatment effect heterogeneity or safety concerns with early compared with late direct oral anticoagulation initiation in people ... |
24 мая 2023 г. · The ELAN trial demonstrated similar safety and efficacy with early versus later DOAC initiation in patients with nonvalvular AF and acute ischemic stroke. |
29 июл. 2023 г. · The ELAN trial provides supporting evidence to encourage clinicians to start DOACs early in patients with AF after acute ischaemic stroke. |
15 июн. 2022 г. · The ELAN trial therefore compares an earlier treatment start (i.e. within 48 h of a minor or moderate stroke and at day 6–7 after a major stroke) ... |
16 мая 2024 г. · We found no evidence of major treatment effect heterogeneity or safety concerns with early compared with late direct oral anticoagulation initiation in people ... |
24 мая 2023 г. · Results of the ELAN trial offer evidence in support of an early anticoagulation strategy in patients with atrial fibrillation and stroke. |
Early versus Late initiation of direct oral Anticoagulants in post-ischaemic stroke patients with atrial fibrillatioN (ELAN): an international, multicentre, ... Не найдено: editorial | Нужно включить: editorial |
| Novbeti > |
| Axtarisha Qayit Anarim.Az Anarim.Az Sayt Rehberliyi ile Elaqe Saytdan Istifade Qaydalari Anarim.Az 2004-2023 |